Delivery Order SPE2DB20D3103-SPE2DB21FQ3P1
Award Date 9/20/21
Potential Completion Date 9/21/21
Potential Value $1.6K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,524.40, is a delivery order for 1,440 units of the HAVRIX vaccine, a hepatitis A vaccine. The contract has a firm fixed price pricing type and an ultimate completion date of February 20, 2024. This award is not associated with a set-aside program. Amerisourcebergen is a...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $1,963.08 firm fixed-price delivery order is for the supply of 4,568,093,069 units of the hepatitis A vaccine HAVRIX 1,440 UNIT/ML SYRINGE. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp also holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $3,722.60 for the supply of 1,440 units of the hepatitis A vaccine HAVRIX 1,440 UNITS/ML SYRINGE. The award was made by the Defense Logistics Agency (DLA), a component of the Department of Defense, and does not have a set-aside designation. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $97,416.00 firm-fixed-price delivery order is for the supply of 1,440 units of the HAVRIX vaccine, a hepatitis A vaccine. The contract has an ultimate completion date of September 30, 2021 and is not designated as a set-aside award. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $24,284.46 firm-fixed-price delivery order is for 1,440 units of the HAVRIX vaccine, a hepatitis A vaccination. The contract has a performance period through May 15, 2023 and does not utilize any set-aside designations. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of 4,561,539,880 units of the hepatitis A vaccine Havrix 1,440 unit/mL syringe. The $1,466.96 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of July 20, 2023. This award is not designated as a set-aside contract. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This firm-fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The $5,501.10 contract is for the delivery of 1,440-unit/mL doses of the hepatitis A vaccine HAVRIX. The award is not designated as a set-aside contract. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $95,377.13 firm fixed-price delivery order is for the supply of HAVRIX 1440 UN 1ML 10S, a hepatitis A vaccine. The award is part of a larger Indefinite Delivery Contract (IDC) between the DLA and Amerisourcebergen, valued at up to $999,999,999.00, which provides a comprehensive range of pharmaceutical products and...
- This federal contract award, valued at $9,211.50, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,557,595 units of the Hepatitis A vaccine HAVRIX 720 in 0.5 mL syringes. The contract is a delivery order awarded under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The $16,944.90 firm fixed-price delivery order is for the supply of 1,440 units of the hepatitis A vaccine HAVRIX 1,440 UNIT/ML SYRINGE. The contract has an ultimate completion date of June 25, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant...